Risk-based evaluation of thromboprophylaxis among surgical inpatients: are low risk patients treated unnecessarily?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Venous thromboembolism is a common source of morbidity and mortality but a variety of preventative measures are available.
To audit the current practice of thromboprophylaxis and compare against published protocols.
Three-hundred and seventy-six (376) surgical patients were surveyed prospectively. A Performa was completed recording the presence of up to 11 risk factors. A risk score was calculated and the use of specific thromboprophylatic measures identified.
Heparin thromboprophylaxis was widely used, eight patients (who were on aspirin therapy) failed to receive any prophylaxis (risk factors 4–6). In addition there were 60 patients at low risk (risk score <2) received LMWH from which they were unlikely to benefit.
Thromboembolic prophylaxis is widely but unselectively applied. Adoption of a risk: benefit ratio approach should ensure those who would benefit from thromboprophylaxis are adequately treated while those in whom thromboprophylaxis is not indicated are spared unnecessary therapy.
- Sevitt, S, Gallagher, NG (1959) Prevention of venous thrombosis and pulmonary embolism in injured patients: a trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur. Lancet ii: pp. 981-989 CrossRef
- Collins, R, Scrimgeour, A, Yusuf, S, Peto, R (1988) Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 318: pp. 1162-1173 CrossRef
- Geerts, WH, Heit, JA, Clagett, GP (2001) Prevention of venous thromboembolism. Chest 119: pp. 132S-175S CrossRef
- Shojania KG, Duncan BW, McDonald KM Making health care safer: a critical analysis of patient safety practices. Evidence Report/Technology Assesment No. 43 (Prepared by the University of California at San Francisco-Stanford Evidence-based Practice Center under Contract No. 290–97–0013). Rockville, MD: Agency for Healthcare Research and Quality, July 2001; 332–346; AHRQ Publication No. 01-E058. Available at http://www.ahrq.gov/clinic/ptsafety/
- Sullivan, SD, Kahn, SR, Davidson, BL, Borris, L, Bossuyt, P, Raskob, G (2003) Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery. Pharmacoeconomics 21: pp. 477-496 CrossRef
- Caprini, JA, Botteman, MF, Stephens, JM (2003) Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health 6: pp. 59-74 CrossRef
- Bick, RL (2000) Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism. Drugs 60: pp. 575-595 CrossRef
- Claggett, GP, Reisch, JS (1988) Prevention of venous thromboembolism in general surgical patients. Result of meta-analysis. Ann Surg 298: pp. 227-240 CrossRef
- Lowe, GDO, Greer, IA, Cooke, TG (1992) Risk of and prophylaxis for thromboembolism in hospital patients. BMJ 305: pp. 567-574 CrossRef
- Gillies, TE, Ruckley, CV, Nixon, SJ (1996) Still missing the boat with fatal pulmonary embolism. Br J Surg 83: pp. 1394-1395 CrossRef
- Eriksson, BI, Lassen, MR (2003) PENTasaccharide in HIp-FRActure surgery plus (PENTHIFRA Plus) invetigators. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 163: pp. 1337-1342 CrossRef
- Douketis, JD, Eikelboom, JW, Quinlan, DJ, Willan, AR, Crowther, MA (2002) Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med 162: pp. 1465-1471 CrossRef
- Kearon, C (2003) Natural history of venous thromboembolism. Circulation 107: pp. I22-I30
- Prandoni, P, Lensing, AW, Cogo, A (1996) The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125: pp. 1-7
- Kahn, SR, Hirsch, A, Shrier, I (2002) Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 162: pp. 1144-1148 CrossRef
- Mismetti, P, Laporte, S, Darmon, JY, Buchmuller, A, Decousus, H (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88: pp. 913-930 CrossRef
- Koch, A, Bouges, S, Ziegler, S, Dinkel, H, Daures, JP, Victor, N (1997) Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses. Br J Surg 84: pp. 750-759 CrossRef
- Warkentin, TE, Levine, MN, Hirsh, J (1995) Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332: pp. 1330-1335 CrossRef
- Kakkar, VV, Boeckl, O, Boneu, B (1997) Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of post-operative venous thromboembolism: European multicenter trial. World J Surg 21: pp. 2-8 CrossRef
- Nurmohamed, MT, Verhaeghe, R, Haas, S (1995) A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of post-operative deep vein thrombosis in general surgery. Am J Surg 169: pp. 567-571 CrossRef
- McLeod, RS, Geerts, WH, Sniderman, KW (2001) Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg 233: pp. 438-444 CrossRef
- Bergqvist, D, Matzsch, T, Burmark, US (1988) Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis. Br J Surg 75: pp. 888-891 CrossRef
- West, E, Newton, J (1997) Clinical guidelines. BMJ 315: pp. 324
- Haycox, A, Bagust, A, Walley, T (1999) Clinical guidelines––the hidden costs. BMJ 318: pp. 391-393
- Grimshaw, JM, Russell, IT (1993) Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342: pp. 1317-1322 CrossRef
- Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 305: pp. 567-574
- Risk-based evaluation of thromboprophylaxis among surgical inpatients: are low risk patients treated unnecessarily?
Irish Journal of Medical Science
Volume 176, Issue 3 , pp 169-173
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Deep venous thrombosis
- Pulmonary embolism
- Risk assessment
- Industry Sectors